Established laboratory control mechanisms are not followed.
Inspection Record
GlaxoSmithKline Vaccines Srl — FDA 483 Findings
Inspectors Roger F ZabinskiThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.
Employees engaged in the manufacture and processing of a drug product lack the training required to perform their assigned functions.
The responsibilities and procedures applicable to the quality control unit are not fully followed.
Not all adverse drug experiences that are both serious and unexpected have been reported to FDA within 15 calendar days of initial receipt of the information.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Baxter Healthcare Corporation2025-11-25 · US FDASimilar to finding 3 Employees engaged in the manufacture and processing of a drug product lack the training required to perform their assigned functions.
- Charles River Laboratories2025-02-07 · US FDASimilar to finding 3 Employees engaged in the manufacture and processing of a drug product lack the training required to perform their assigned functions.
- Sterigenics US , LLC2022-08-23 · US FDASimilar to finding 4 The responsibilities and procedures applicable to the quality control unit are not fully followed.
- Glenmark Pharmaceuticals Inc USA2022-05-19 · US FDASimilar to finding 3 Employees engaged in the manufacture and processing of a drug product lack the training required to perform their assigned functions.
- Aurobindo Pharma Limited Unit 162019-03-01 · US FDASimilar to finding 3 Employees engaged in the manufacture and processing of a drug product lack the training required to perform their assigned functions.
A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.